Aim 3: Identify, support, and facilitate scientific collaborations.Aim 2: Develop, facilitate and monitor progress of translational aims with project Co-Leaders.Aim 1: Provide scientific, programmatic and administrative leadership to all aspects of the SPORE.The SPORE Administration Core is guided by the following Specific Aims: The Administration Core oversees all aspects and performs numerous duties across the wide scope of the SPORE to support the translational goals of the investigators. The Michigan Prostate SPORE Administration Core is responsible for the leadership, guidance and management of this proposal. Ganesh Palapattu, M.D., FACS (Core Co-Director).Elisabeth Heath, M.D., FACP (Core Co-Director).Karmanos Cancer Institute researchers participate in the following: Administration Core Professor and Chair, Department of Urology George F and Sandy G Valassis Professor of Urology Leader, Genitourinary Oncology Multidisciplinary Team University of Michigan Rogel Cancer CenterĪssociate Center Director, Translational Sciences Investigator, Howard Hughes Medical Institute Professor, Department of Pathology and Urology Hicks Endowed Professor of Pathologyĭirector, Michigan Center for Translational Pathology Project 3: Exploring Ablation of the Androgen Receptor as a Therapeutic Approach for mCRPC.Project 2: Integrating a Novel MiPS-Based Next- Generation Sequencing Urine Assay for the Early Detection of Unfavorable Risk PCa.Project 1: Targeting mCRPC Patients with Biallelic Loss of CDK12.The current Michigan SPORE consists of three projects: The Michigan Prostate SPORE supports an interactive group of basic and clinical investigators in a translational research program that has led to major discoveries in the diagnosis, prevention, and treatment of PCa. Karmanos has a non-overlapping patient population as U-M that includes an underserved population. In the 2018 Prostate SPORE renewal proposal from the University of Michigan (U-M), Karmanos Cancer Institute joined forces with U-M to propose a “Michigan Prostate SPORE” leveraging our institutions’ respective areas of strength.
Clinical Trials by Tumor Biology & Microbiology Program Members.Tumor Biology and Microenvironment Research Program.Population Studies and Disparities - Ultra-Orthodox Jewish Cancer Research.Population Studies and Disparities - Prostate Cancer Research.Population Studies and Disparities - Pediatric Cancer Research.Population Studies and Disparities - Lung Cancer Research.Population Studies and Disparities - Colon Cancer Research.Population Studies and Disparities - Breast & Endometrial Cancer Research.Population Studies and Disparities - Arab American Cancer Research.Population Studies & Disparities - Arab Americans & Lung Cancer Research.Population Studies & Disparities - African American Cancer Research.Population Studies and Disparities Scientific Themes.Population Studies & Disparities Research Publications.Population Studies & Disparities Research Program Outreach Initiatives.Population Studies & Disparities Program Members.Population Studies & Disparities Research Program.Office of Cancer Health Equity and Community Engagement.Molecular Therapeutics Selected Publications.Molecular Therapeutics Theme 3 Accomplishments.Molecular Therapeutics Theme 2 Accomplishments.Molecular Therapeutics Theme 1 Accomplishments.Molecular Therapeutics Scientific Themes.Molecular Therapeutics Outreach Initiatives.Molecular Therapeutics Research Program.Molecular Imaging Theme 2 Accomplishments.Molecular Imaging Theme 1 Accomplishments.Education and Research Training Programs.Office of Cancer Research, Training and Education.Microscopy, Imaging and Cytometry Resources Core.Biobanking and Correlative Sciences Core.Animal Model and Therapeutics Evaluation Core.Eisenberg Center for Translational Therapeutics.Prostate Cancer SPORE menu Karmanos Research